Impacts of β-1, 3-N-acetylglucosaminyltransferases (B3GNTs) in human diseases

Mol Biol Rep. 2024 Mar 29;51(1):476. doi: 10.1007/s11033-024-09405-9.ABSTRACTGlycosylation modification of proteins is a common post-translational modification that exists in various organisms and has rich biological functions. It is usually catalyzed by multiple glycosyltransferases located in the Golgi apparatus. β-1,3-N-acetylglucosaminyltransferases (B3GNTs) are members of the glycosyltransferases and have been found to be involved in the occurrence and development of a variety of diseases including autoimmunity diseases, cancers, neurodevelopment, musculoskeletal system, and metabolic diseases. The functions of B3GNTs represent the glycosylation of proteins is a crucial and frequently life-threatening step in progression of most diseases. In this review, we give an overview about the roles of B3GNTs in tumor, nervous system, musculoskeletal and metabolic diseases, describing the recent results about B3GNTs, in order to provide a research direction and exploration value for the prevention, diagnosis and treatment of these diseases.PMID:38553573 | DOI:10.1007/s11033-024-09405-9
Source: Molecular Biology Reports - Category: Molecular Biology Authors: Source Type: research